NYSE · Healthcare · Medical Instruments & Supplies · USA
Aptargroup Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.
Aptargroup Inc creates and produces application and protection systems for medications and consumer products served across pharmaceutical, fragrance, cosmetics, food, beverage, personal care and home care sectors. The company operates three segments: Pharma, Beauty, and Closures, offering pumps, valves, sealing solutions, elastomeric components for injectable use, material science technologies and connected health platforms.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Aptargroup Inc stock.
Fairly valued: intrinsic value $129.04 per share, market price $125.77, margin of safety 2.5% (as of 2026-10-20).
Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $129.04; the price of $125.77 is 3% below that value, and 82% of that value comes from beyond year five.
Leak Score: 59/100 on 12 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
ATR is fairly valued (as of the 2026-10-20 close). Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $129.04; the price of $125.77 is 3% below that value, and 82% of that value comes from beyond year five.
$129.04 per share (as of the 2026-10-20 close), against a market price of $125.77. That is a margin of safety of 2.5%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
59 out of 100, which we rate "Weak Signal", on 12 of 12 value investing signals.